Shanda Asset Management Holdings’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,000
Closed -$6.31M 16
2021
Q4
$6.31M Hold
29,000
0.84% 25
2021
Q3
$5.49M Sell
29,000
-14,472
-33% -$2.64M 0.57% 40
2021
Q2
$7.68M Hold
43,472
0.63% 37
2021
Q1
$7.13M Hold
43,472
0.59% 35
2020
Q4
$6.05M Hold
43,472
0.33% 41
2020
Q3
$4.86M Hold
43,472
0.33% 40
2020
Q2
$4.04M Hold
43,472
0.36% 44
2020
Q1
$3.19M Buy
43,472
+16,590
+62% +$1.44M 0.74% 24
2019
Q4
$2.26M Buy
26,882
+15,000
+126% +$1.16M 0.44% 21
2019
Q3
$999K Sell
11,882
-15,000
-56% -$1.13M 0.19% 25
2019
Q2
$1.76M Hold
26,882
0.33% 14
2019
Q1
$1.58M Buy
26,882
+25,244
+1,541% +$1.51M 0.26% 24
2018
Q4
$87K Buy
+1,638
New +$89.9K 0.02% 48

Other funds holding MEDP

Shanda Asset Management Holdings's MEDP Position: Q1 2022 in Review

Shanda Asset Management Holdings sold out of Medpace (MEDP) in Q1 2022, closing a stake of 29,000 shares — an estimated $6.31M sold.

Shanda Asset Management Holdings first reported a position in MEDP in Q4 2018 and held it in 13 quarters. The position peaked at $7.68M in Q2 2021. 349 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.

  • Shanda Asset Management Holdings reported no remaining Medpace position as of Q1 2022 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 29,000 Medpace shares in Q1 2022, an estimated $6.31M.
  • Shanda Asset Management Holdings first reported a position in Medpace in Q4 2018 and held it in 13 quarters.
  • Shanda Asset Management Holdings's Medpace position peaked at $7.68M in Q2 2021.
  • 349 funds tracked by Wall St. Rank held Medpace as of Q1 2022.

Based on Shanda Asset Management Holdings's 13F filing for Q1 2022, filed 16 May 2022.